International development of the patient-reported outcome indices for multiple sclerosis (PRIMUS)

Value in Health

Volumn 13, Issue 8, 2010, Pages 946-951

  McKenna, Stephen P ^a   Doward, Lynda C ^a   Twiss, James ^a   Hagell, Peter ^b   Oprandi, Nadia C ^c   Fisk, John ^d   Grand'Maison, François ^e   Bhan, Virender ^d   Arbizu, Txomin ^f   Brassat, David ^g   Kohlmann, Thomas ^h   Meads, David M ^a   Eckert, Benjamin J ⁱ  

^a GALEN RESEARCH   (United Kingdom)

^b LUND UNIVERSITY   (Sweden)

^c UNIVERSITY OF VERONA   (Italy)

^d DALHOUSIE UNIVERSITY   (Canada)

^e UNIVERSITÉ DE SHERBROOKE   (Canada)

^f UNIVERSITY OF BARCELONA   (Spain)

^g UNIVERSITÉ DE TOULOUSE   (France)

^h UNIVERSITY OF GREIFSWALD   (Germany)

ⁱ NOVARTIS PHARMA AG   (Switzerland)

Author keywords

activities; multiple sclerosis; patient reported outcomes; PRIMUS; quality of life; questionnaire; symptoms

Indexed keywords

ADULT; ARTICLE; COGNITION; CONTENT VALIDITY; DEMOGRAPHY; DISEASE SEVERITY; FEMALE; HEALTH SURVEY; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; OUTCOME ASSESSMENT; PATIENT REPORTED INDICES FOR MULTIPLE SCLEROSIS; PRIORITY JOURNAL; PSYCHOMETRY; QUALITY OF LIFE; RATING SCALE; SELF REPORT;

EID: 77958496958     PISSN: 10983015     EISSN: 15244733     Source Type: Journal    
DOI: 10.1111/j.1524-4733.2010.00767.x     Document Type: Article

References (16)

1. Mohr DC, Pelletier D,. A temporal framework for understanding the effects of stressful life events on inflammation in patients with multiple sclerosis. Brain Behav Immun 2005; 12: 1-10.
2. Andlin-Sobocki P, Jönsson B, Wittchen HU, et al. Cost of disorders of the brain in Europe. Eur J Neurol 2005; 12 (Suppl. 1): 1-27.
3. Jacobson DL, Gange SJ, Rose NR, Graham NM,. Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin Immunol Immunopathol 1997; 84: 223-43.
4. Cooper GS, Stroehla BC,. The epidemiology of autoimmune diseases. Autoimmun Rev 2003; 2: 119-25.
5. Johnson KL, Amtmann D, Yorkston K, et al. Medical, psychological, social, and programmatic barriers to employment for people with multiple sclerosis. J Rehabil 2004; 70: 38-49.
6. Doward LC, McKenna SP, Meads DM, et al. The development of Patient Reported Outcome Indices for Multiple Sclerosis (PRIMUS). Mult Scler 2009; 15: 1092-102.
7. Swaine-Verdier A, Doward LC, Hagell P, et al. Adapting quality of life instruments. Value Health 2004; 7 (Suppl.): S27-30.
8. Meads DM, Doward LC, McKenna SP, et al. The development and validation of the Unidimensional Fatigue Impact Scale (U-FIS). Mult Scler 2009; 15: 1228-38.
9. Doward LC, Meads DM, Fisk J, et al. International development of the Unidimensional Fatigue Impact Scale (U-FIS). Value Health 11 March 2010 [Epub ahead of print.
10. Hunt SM, McEwen J, McKenna SP,. Measuring Health Status. London: Croom Helm, 1986.
11. European Group for Quality of Life Assessment and Health Measurement. European Guide to the Nottingham Health Profile. Brookwood, Surrey: Brookwood Medical Publications, 1993.
12. Fisk JD, Ritvo PG, Ross L, et al. Measuring the functional impact of fatigue: initial validation of the fatigue impact scale. Clin Infect Dis 1994; 18 (Suppl. 1): S79-83.
13. Rasch G,. Probabilistic Models for Some Intelligence and Attainment Tests. Copenhagen: Danish Institute for Educational Research, 1960. (Expanded edition, Chicago: The University of Chicago Press, 1980).
14. Holland PW, Wainer H, eds. Differential Item Functioning. New Jersey: Lawrence Erlbaum Associates, 1993.
15. Nunally JC Jr,. Psychometric Theory (2nd ed.). New York: McGraw-Hill, 1978.
16. Streiner D, Norman G,. Health Measurement Scales. Oxford: Oxford University Press, 1989.